Zhang Z, et al. Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice. Am J Transplant 2018; 18:1646–1656. doi: 10.1111/ajt.14661

• PubMed
Zhang Z, Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice. Am J Transplant 2018; 18:1646–1656. doi: 10.1111/ajt.14661 )| false
• Search Google Scholar
• Export Citation

Magruder M, et al. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun 2019; 10:5521. doi: 10.1038/s41467-019-13467-w

• PubMed
Magruder M, Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun 2019; 10:5521. doi: 10.1038/s41467-019-13467-w )| false
• Search Google Scholar
• Export Citation

Lee JR, et al. Gut microbiota dysbiosis and diarrhea in kidney transplant recipients. Am J Transplant 2019; 19:488–500. doi: 10.1111/ajt.14974

• PubMed
Lee JR, Gut microbiota dysbiosis and diarrhea in kidney transplant recipients. Am J Transplant 2019; 19:488–500. doi: 10.1111/ajt.14974 )| false
• Search Google Scholar
• Export Citation

Lee JR, et al. Gut microbiota and tacrolimus dosing in kidney transplantation. PLoS One 2015; 10:e0122399. doi: 10.1371/journal.pone.0122399

• PubMed
Lee JR, Gut microbiota and tacrolimus dosing in kidney transplantation. PLoS One 2015; 10:e0122399. doi: 10.1371/journal.pone.0122399 )| false
• Search Google Scholar
• Export Citation

Lopez-Siles M, et al. Faecalibacterium prausnitzii: From microbiology to diagnostics and prognostics. ISME J 2017; 11:841–852. doi: 10.1038/ismej.2016.176

• PubMed
Lopez-Siles M, Faecalibacterium prausnitzii: From microbiology to diagnostics and prognostics. ISME J 2017; 11:841–852. doi: 10.1038/ismej.2016.176 )| false
• Search Google Scholar
• Export Citation

Guo Y, et al. Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites. Drug Metab Dispos 2019; 47:194–202. doi: 10.1124/dmd.118.084772

• PubMed
Guo Y, Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites. Drug Metab Dispos 2019; 47:194–202. doi: 10.1124/dmd.118.084772 )| false
• Search Google Scholar
• Export Citation

Guo Y, et al. Blood profiles of gut bacterial tacrolimus metabolite in kidney transplant recipients. Transplant Direct 2020; 6:e601. doi: 10.1097/TXD.0000000000001052

• PubMed
Guo Y, Blood profiles of gut bacterial tacrolimus metabolite in kidney transplant recipients. Transplant Direct 2020; 6:e601. doi: 10.1097/TXD.0000000000001052 )| false
• Search Google Scholar
• Export Citation

Taylor MR, et al. Vancomycin relieves mycophenolate mofetil-induced gastrointestinal toxicity by eliminating gut bacterial beta-glucuronidase activity. Sci Adv 2019; 5:eaax2358. doi: 10.1126/sciadv.aax2358

• PubMed
Taylor MR, Vancomycin relieves mycophenolate mofetil-induced gastrointestinal toxicity by eliminating gut bacterial beta-glucuronidase activity. Sci Adv 2019; 5:eaax2358. doi: 10.1126/sciadv.aax2358 )| false
• Search Google Scholar
• Export Citation

Zhang LT, et al. Gut microbiota profiles and fecal beta-glucuronidase activity in kidney transplant recipients with and without post-transplant diarrhea. Clin Transplant [published online ahead of print February 19, 2021]. doi: 10.1111/ctr.14260; https://onlinelibrary.wiley.com/doi/10.1111/ctr.14260

• PubMed
Zhang LT, Gut microbiota profiles and fecal beta-glucuronidase activity in kidney transplant recipients with and without post-transplant diarrhea. Clin Transplant [published online ahead of print February 19, 2021]. doi: 10.1111/ctr.14260; https://onlinelibrary.wiley.com/doi/10.1111/ctr.14260 )| false
• Search Google Scholar
• Export Citation